[ET Net News Agency, 22 June 2022] CKLIFE SCIENCES (00775) rose 32.31% to HK$0.86,
breaking above the 250-D SMA of HK$0.714.
It hits an intra-day high of HK$0.86, hitting an 1-month high, and an intra-day low of
HK$0.66. The total shares traded was 34.91 million, with a value of HK$26.96m. The active
buy/sell ratio is 74:26, with net buying turnover of HK$12.67m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$1.29m, with volume weighted
average price of HK$0.781. SANFULL SEC accounts for greatest net responsive selling
turnover of HK$1.6m, with volume weighted average price of HK$0.769.
The Hang Seng Index now fell 144 points, or 0.67% to 21,415; the Hang Seng China
Enterprises Index now fell 56 points, or 0.75% to 7,492; the Hang Seng TECH Index now fell
51 points, or 1.08% to 4,708; with an overall turnover of HK$19.75b.
The SSE Composite Index now fell 10 points, or 0.32% to 3,296, with an overall turnover
of RMB78.72b.
The SZSE Component Index now fell 61 points, or 0.49% to 12,362, with an overall
turnover of RMB52.9b.

Basic Information
=================

----------------------------------
Nominal 0.860 % Chg +32.31%
High 0.860 Low 0.660
Shares Tr 34.91m Turnover 26.96m
10-D SMA 0.676 %H.V 26.154
20-D SMA 0.648 VWAP 0.772
50-D SMA 0.621 RSI14 85.140
----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
74:26, with net buying turnover of HK$12.67m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CKLIFE SCIENCES (00775) 0.860 +32.31
SIHUAN PHARM (00460) 1.260 +3.28
TRAD CHI MED (00570) 4.400 +6.28
NT PHARMA (01011) 0.237 +11.27
CSPC PHARMA (01093) 7.440 Unchanged
SINO BIOPHARM (01177) 4.480 -1.32
FOSUN PHARMA (02196) 30.600 -1.29
WUXI APPTEC (02359) 99.350 -0.65
CHINARES PHARMA (03320) 5.030 +1.00
PHARMARON (03759) 71.300 -0.83
-----------------------------------------------
(ed)